These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11050644)

  • 1. Age-related blood half-life of particulate contrast material: experimental results with a USPIO in rats.
    Schnorr J; Taupitz M; Wagner S; Pilgrimm H; Hansel J; Hamm B
    J Magn Reson Imaging; 2000 Nov; 12(5):740-4. PubMed ID: 11050644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
    Kaufels N; Korn R; Wagner S; Schink T; Hamm B; Taupitz M; Schnorr J
    Invest Radiol; 2008 Jul; 43(7):496-503. PubMed ID: 18580332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat.
    Majumdar S; Zoghbi SS; Gore JC
    Invest Radiol; 1990 Jul; 25(7):771-7. PubMed ID: 2391194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging.
    Lutz AM; Seemayer C; Corot C; Gay RE; Goepfert K; Michel BA; Marincek B; Gay S; Weishaupt D
    Radiology; 2004 Oct; 233(1):149-57. PubMed ID: 15333767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
    Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
    Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver and spleen enhancement after intravenous injection of carboxydextran magnetite: effect of dose, delay of imaging, and field strength in an ex vivo model.
    Caramella D; Jin XN; Mascalchi M; Agen C; Petruzzi P; Kresse M; Bianucci D; Ceretti E; Semmler W; Bartolozzi C
    MAGMA; 1996; 4(3-4):225-30. PubMed ID: 9220411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.
    Hamm B; Staks T; Taupitz M; Maibauer R; Speidel A; Huppertz A; Frenzel T; Lawaczeck R; Wolf KJ; Lange L
    J Magn Reson Imaging; 1994; 4(5):659-68. PubMed ID: 7981510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
    Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance lymphography in rats: effects of muscular activity and hyperthermia on the lymph node uptake of intravenously injected superparamagnetic iron oxide particles.
    Elste V; Wagner S; Taupitz M; Pfefferer D; Kresse M; Hamm B; Berg R; Wolf KJ; Semmler W
    Acad Radiol; 1996 Aug; 3(8):660-6. PubMed ID: 8796730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran magnetite as a liver contrast agent.
    Magin RL; Bacic G; Niesman MR; Alameda JC; Wright SM; Swartz HM
    Magn Reson Med; 1991 Jul; 20(1):1-16. PubMed ID: 1943651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent.
    Enochs WS; Harsh G; Hochberg F; Weissleder R
    J Magn Reson Imaging; 1999 Feb; 9(2):228-32. PubMed ID: 10077018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MRI of arthritis with the USPIO SH U 555 C: optimization of T1 enhancement].
    Simon G; Daldrup-Link H; von Vopelius-Feldt J; Wendland M; Fu Y; Schlegel J; Rummeny E
    Rofo; 2006 Feb; 178(2):200-6. PubMed ID: 16435251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
    Reimer P; Kwong KK; Weisskoff R; Cohen MS; Brady TJ; Weissleder R
    J Magn Reson Imaging; 1992; 2(2):177-81. PubMed ID: 1562768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms.
    Laghi A; Paolantonio P; Panebianco V; Miglio C; Iafrate F; Di Tondo U; Passariello R
    Invest Radiol; 2004 Nov; 39(11):666-70. PubMed ID: 15486527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan, (NC100150) for MRI of renal perfusion: experimental study in an animal model.
    Bachmann R; Conrad R; Kreft B; Luzar O; Block W; Flacke S; Pauleit D; Träber F; Gieseke J; Saebo K; Schild H
    J Magn Reson Imaging; 2002 Aug; 16(2):190-5. PubMed ID: 12203767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer.
    Nolte-Ernsting C; Adam G; Bücker A; Berges S; Bjørnerud A; Günther RW
    AJR Am J Roentgenol; 1998 Jul; 171(1):107-13. PubMed ID: 9648772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent.
    Josephson L; Groman EV; Menz E; Lewis JM; Bengele H
    Magn Reson Imaging; 1990; 8(5):637-46. PubMed ID: 1707120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats.
    Kaim AH; Wischer T; O'Reilly T; Jundt G; Fröhlich J; von Schulthess GK; Allegrini PR
    Radiology; 2002 Dec; 225(3):808-14. PubMed ID: 12461265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.